東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Drug Delivery Systems and Combinatio...

Kydd, Janel Lauren.

FindBook

Google Book

Amazon

博客來

Drug Delivery Systems and Combination Therapy for Oncomedicine.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Drug Delivery Systems and Combination Therapy for Oncomedicine./
作者:	Kydd, Janel Lauren.
出版者:	Ann Arbor : ProQuest Dissertations & Theses, : 2019,
面頁冊數:	192 p.
附註:	Source: Dissertations Abstracts International, Volume: 80-12, Section: B.
Contained By:	Dissertations Abstracts International80-12B.
標題:	Bioengineering. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=13883587
ISBN:	9781392265482

Drug Delivery Systems and Combination Therapy for Oncomedicine.
Kydd, Janel Lauren.

Drug Delivery Systems and Combination Therapy for Oncomedicine. - Ann Arbor : ProQuest Dissertations & Theses, 2019 - 192 p.

Source: Dissertations Abstracts International, Volume: 80-12, Section: B.

Thesis (Ph.D.)--University of Massachusetts Lowell, 2019.

This item must not be sold to any third party vendors.

Cancer treatment offers one of the biggest challenges to the healthcare in the United States and across the world. Even if the primary tumor gets cured, the complexity of this diseases often causes relapse affecting the standard of living of the patients. The relapse is often the difficult to treat using the same treatment. This is attributed to the resistance offered by tumor towards a single agent. Using combination treatment/ therapies can overcome this this drug resistance. In this dissertation, a combination treatment was used incorporating photodynamic therapy and chemotherapy. The limitations of these therapies include poor drug solubility and bioavailability resulting in reduced therapeutic efficiency. The objective of this research was to improve the bioavailability of the drugs used in chemotherapy and PDT by integrating nanotechnology to deliver the payload selectively to the tumor cells. The drug delivery systems (DDS) used in both above-mentioned therapies were polyethylene glycol coated (PEGylated) polymer-based (poly lactic-co-glycolic acid (PLGA)) nanoparticles.This study aims at determining the optimal delivery route of a chemotherapeutic (anti-angiogenic) drug Cedarinib and a photosensitizer, Verteporfin. The study was design to compare the encapsulated form of these agents when administered separately in two different nanoparticles or when both the drugs are administered together in single nanosystem. The results showed that the co-administration of these drugs using separate nanoparticles for each drug showed greater therapeutic efficiency in vitro.

ISBN: 9781392265482Subjects--Topical Terms:

657580
Bioengineering.

Drug Delivery Systems and Combination Therapy for Oncomedicine.
LDR:02692nmm a2200337 4500 001 2208926
005 20191025102444.5
008 201008s2019 ||||||||||||||||| ||eng d
020 $a 9781392265482
035 $a (MiAaPQ)AAI13883587
035 $a (MiAaPQ)uml:10098
035 $a AAI13883587
040 $a MiAaPQ $c MiAaPQ
100 1 $a Kydd, Janel Lauren. $3 3435995
245 1 0 $a Drug Delivery Systems and Combination Therapy for Oncomedicine.
260 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2019
300 $a 192 p.
500 $a Source: Dissertations Abstracts International, Volume: 80-12, Section: B.
500 $a Publisher info.: Dissertation/Thesis.
500 $a Advisor: Moore, Jeffrey;Rai, Prakash.
502 $a Thesis (Ph.D.)--University of Massachusetts Lowell, 2019.
506 $a This item must not be sold to any third party vendors.
520 $a Cancer treatment offers one of the biggest challenges to the healthcare in the United States and across the world. Even if the primary tumor gets cured, the complexity of this diseases often causes relapse affecting the standard of living of the patients. The relapse is often the difficult to treat using the same treatment. This is attributed to the resistance offered by tumor towards a single agent. Using combination treatment/ therapies can overcome this this drug resistance. In this dissertation, a combination treatment was used incorporating photodynamic therapy and chemotherapy. The limitations of these therapies include poor drug solubility and bioavailability resulting in reduced therapeutic efficiency. The objective of this research was to improve the bioavailability of the drugs used in chemotherapy and PDT by integrating nanotechnology to deliver the payload selectively to the tumor cells. The drug delivery systems (DDS) used in both above-mentioned therapies were polyethylene glycol coated (PEGylated) polymer-based (poly lactic-co-glycolic acid (PLGA)) nanoparticles.This study aims at determining the optimal delivery route of a chemotherapeutic (anti-angiogenic) drug Cedarinib and a photosensitizer, Verteporfin. The study was design to compare the encapsulated form of these agents when administered separately in two different nanoparticles or when both the drugs are administered together in single nanosystem. The results showed that the co-administration of these drugs using separate nanoparticles for each drug showed greater therapeutic efficiency in vitro.
590 $a School code: 0111.
650 4 $a Bioengineering. $3 657580
650 4 $a Chemical engineering. $3 560457
650 4 $a Nanoscience. $3 587832
690 $a 0202
690 $a 0542
690 $a 0565
710 2 $a University of Massachusetts Lowell. $b Biomedical Engineering. $3 3435996
773 0 $t Dissertations Abstracts International $g 80-12B.
790 $a 0111
791 $a Ph.D.
792 $a 2019
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=13883587